Prevention of cardiovascular disease Vitamin d,
Conditions
Interventions
Vitamin D2 (calciferol) 40,
000 unit per week,Placebo drug look alike vitamin D2 taken weekly
Experimental Drug,Placebo Comparator Drug
Sponsors
Faculty of medicine siriraj hospital
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Female aged 40-60 years old History of last menstruation more than 12 months or FSH >40 IU/mL History of bilateral oophorectomy before age 50 years old from any condition
Exclusion criteria
Exclusion criteria: Previous diagnosed CVD Previous diagnosed DM Current use antidiabetic or lipid lowering drugs Current use of vitamin d supplement Chronic kidney disease History of smoking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hsCRP 12 weeks Mean difference between two study group | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolic indices(FPG, lipid profiles, HOMA-IR), 25-hydroxyvitamin D level 12 weeks Mean difference between two study group | — |
Countries
Thailand
Contacts
Public ContactWorawat Boonyachan
Faculty of medicine siriraj hospital
Outcome results
None listed